|
|
|
|
GMMMG Consultations |
|
|
On this page you will find proposed changes that are currently going through the GMMMG approval process. This will include consultations on proposed RAG status, updated Formulary Chapters, Pathways or other GMMMG Guidance. You will be able to comment on current proposals via the links in the table below. |
|
|
Title |
Information |
Feedback |
End date |
|
|
71 |
Ustekinumab Crohns disease GMMMG Commissioning Statement |
A ustekinumab Crohns disease commissioning statement [Link removed - consultation closed] is available for consultation. We now seek comments [Link removed - consultation closed] on this document. This consultation period is open until 5pm Wednesday 27th November. |
Feedback Form |
5pm Wednesday |
|
70 |
Liothyronine injection GMMMG Commissioning Statement |
A liothyronine injection commissioning statement [Link removed - consultation closed] is available for consultation. We now seek comments [Link removed - consultation closed] on this document. This consultation period is open until 5pm Wednesday 27th November. |
Feedback Form |
5pm Wednesday |
|
69 |
PaGDSG Shared Care Protocol for Penicillamine for Rheumatoid Arthritis or Wilsons disease in Adults |
On behalf of the GMMMG Pathways and Guidelines Development Subgroup, a Greater Manchester-wide Shared Care Protocol for Penicillamine for Rheumatoid Arthritis or Wilsons disease in Adults [Link removed - consultation closed] is in development. We now seek comments [Link removed - consultation closed] on this draft. This consultation period is open until 5pm Wednesday 27th November. |
Feedback Form |
5pm Wednesday |
<< Back
